WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012117323) THERAPEUTIC CANCER VACCINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/117323    International Application No.:    PCT/IB2012/050876
Publication Date: 07.09.2012 International Filing Date: 27.02.2012
IPC:
A61K 39/00 (2006.01), A61P 35/00 (2006.01)
Applicants: CADILA PHARMACEUTICALS LIMITED [IN/IN]; "Cadila Corporate Campus", Sarkhej - Dholka Road, Bhat, Ahmedabad, Gujarat 382210 (IN) (For All Designated States Except US).
KHAMAR, Bakulesh Mafatlal [IN/IN]; (IN) (For US Only).
DESAI, Nirav Manojkumar [IN/IN]; (IN) (For US Only).
SHUKLA, Chandreshwar Prasad [IN/IN]; (IN) (For US Only).
DARJI, Avani Devenbhai [IN/IN]; (IN) (For US Only).
MODI, Indravadan Ambalal [IN/IN]; (IN) (For US Only)
Inventors: KHAMAR, Bakulesh Mafatlal; (IN).
DESAI, Nirav Manojkumar; (IN).
SHUKLA, Chandreshwar Prasad; (IN).
DARJI, Avani Devenbhai; (IN).
MODI, Indravadan Ambalal; (IN)
Common
Representative:
KHAMAR, Bakulesh Mafatlal; Cadila Pharmaceuticals Limited, "Cadila Corporate campus" Sarkhej - Dholka Road, Bhat Ahmedabad, Gujarat 382210 (IN)
Priority Data:
555/MUM/2011 28.02.2011 IN
Title (EN) THERAPEUTIC CANCER VACCINE
(FR) VACCIN THÉRAPEUTIQUE CONTRE LE CANCER
Abstract: front page image
(EN)The present invention relates to vaccine(s) comprising cancer cells expressing antigen(s), excipients, optionally adjuvant wherein the said antigen(s) is expressed on contacting the said cancer cell with p38 inducer, for use in treatment of Cancer. The vaccine composition induces specific immune response against homologous and heterologus cancer cells of the tissue /organ. The invention also provides method of preparing the same.
(FR)La présente invention concerne un (des) vaccin(s) comprenant des cellules cancéreuses exprimant un ou plusieurs antigènes, des excipients, facultativement un adjuvant, ledit ou lesdits antigènes étant exprimés lors de la mise en contact de ladite cellule cancéreuse avec un inducteur de p38, destinés à être utilisés dans traitement du cancer. La composition vaccinale induit une réponse immunitaire spécifique contre des cellules cancéreuses homologues et hétérologues du tissu/de l'organe. L'invention concerne en outre un procédé de préparation associé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)